Nottingham Respiratory Research Unit

Study Investigating the Safety and Efficacy of Nalbuphine Extended-Release Tablets (NAL ER)

We have recently commenced a new study led at Nottingham University Hospitals NHS Trust by Gr Gauri Saini, to assess the efficacy and...

We have just commenced recruiting patients into a new trial which funded by an NIHR HTA Grant with Chief Investigator Professor Andrew...

We will be shortly commencing a new study to find out if it is practical for patients with a fibrotic lung disease, to take their own...

Dr Amanda Goodwin , Dr Amanda Tatler and Dr Rachel Clifford , along with many other researchers in Translational Medical Science at the...

Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease: An International Multicenter Study

The Group will nvestigate the pathogenesis, treatment and complications of lung disease caused by the SARS-CoV-2 virus

This exciting event was organised by Natalie Stevenson, Lucy Howard and Dr Fasihul Khan from the ILD team of the University of Nottingham